These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19275923)

  • 1. Lack of significant de novo HLA allosensitization in ventricular assist device recipients transfused with leukoreduced, ABO identical blood products.
    Coppage M; Baker M; Fialkow L; Meehan D; Gettings K; Chen L; Massey HT; Blumberg N
    Hum Immunol; 2009 Jun; 70(6):413-6. PubMed ID: 19275923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions.
    Drakos SG; Stringham JC; Long JW; Gilbert EM; Fuller TC; Campbell BK; Horne BD; Hagan ME; Nelson KE; Lindblom JM; Meldrum PA; Carlson JF; Moore SA; Kfoury AG; Renlund DG
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1612-9. PubMed ID: 17532964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA and MICA allosensitization patterns among patients supported by ventricular assist devices.
    Askar M; Hsich E; Reville P; Nowacki AS; Baldwin W; Bakdash S; Daghstani J; Zhang A; Klingman L; Smedira N; Moazami N; Taylor DO; Starling RC; Gonzalez-Stawinski G
    J Heart Lung Transplant; 2013 Dec; 32(12):1241-8. PubMed ID: 24075503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization.
    Stringham JC; Bull DA; Fuller TC; Kfoury AG; Taylor DO; Renlund DG; Karwande SV
    J Heart Lung Transplant; 1999 Feb; 18(2):160-5. PubMed ID: 10194040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.
    Drakos SG; Kfoury AG; Long JW; Stringham JC; Fuller TC; Nelson KE; Campbell BK; Gilbert EM; Renlund DG
    Ann Thorac Surg; 2006 Sep; 82(3):889-93. PubMed ID: 16928502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization.
    Drakos SG; Kfoury AG; Kotter JR; Reid BB; Clayson SE; Selzman CH; Stehlik J; Fisher PW; Merida M; Eckels DD; Brunisholz K; Horne BD; Stoker S; Li DY; Renlund DG
    J Heart Lung Transplant; 2009 Aug; 28(8):838-42. PubMed ID: 19632582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of ventricular assist device-mediated sensitization in the bridge-to-heart-transplantation patient.
    Kwon MH; Zhang JQ; Schaenman JM; Cadeiras M; Gjertson DW; Krystal CA; Laks H; Ardehali A; Deng MC; Shemin RJ; Reed EF
    J Thorac Cardiovasc Surg; 2015 Apr; 149(4):1161-6. PubMed ID: 25702320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De Novo Human Leukocyte Antigen Allosensitization in Heartmate 3 Versus Heartmate II Left Ventricular Assist Device Recipients.
    Jain R; Habal MV; Clerkin KJ; Latif F; Restaino SW; Zorn E; Takeda K; Naka Y; Yuzefpolskaya M; Farr MA; Colombo PC; Sayer GT; Uriel N; Topkara VK
    ASAIO J; 2022 Feb; 68(2):226-232. PubMed ID: 33883507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation.
    Ashimine S; Watarai Y; Yamamoto T; Hiramitsu T; Tsujita M; Nanmoku K; Goto N; Takeda A; Katayama A; Uchida K; Kobayashi T
    Kidney Int; 2014 Feb; 85(2):425-30. PubMed ID: 23945498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion-related immunomodulation: gamma irradiation alters the effects of leukoreduction on alloimmunization.
    Nelson KA; Aldea GS; Warner P; Latchman Y; Gunasekera D; Tamir A; Gernsheimer T; Bolgiano D; Slichter SJ
    Transfusion; 2019 Nov; 59(11):3396-3404. PubMed ID: 31608454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo human leukocyte antigen allosensitization patterns in patients bridged to heart transplantation using left ventricular assist devices.
    Chau VQ; Feinman J; Fullin K; Mahmood K; Oliveros E; Mitter SS; Pinney SP; Mancini DM; Lala A; Moss N
    Transpl Immunol; 2022 Jun; 72():101567. PubMed ID: 35278648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of allosensitized cardiac transplant candidates.
    Velez M; Johnson MR
    Transplant Rev (Orlando); 2009 Oct; 23(4):235-47. PubMed ID: 19778695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing HLA sensitization in implantable LVAD recipients.
    Massad MG; Cook DJ; Schmitt SK; Smedira NG; McCarthy JF; Vargo RL; McCarthy PM
    Ann Thorac Surg; 1997 Oct; 64(4):1120-5. PubMed ID: 9354538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitisation and post-transplant course after the implantation of ventricular assist device.
    Malickaite R; Rucinskas K; Staneviciene A; Miniauskas S; Maneikiene V; Zuoziene G; Sirvydis V
    Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):339-42; discussion 342-3. PubMed ID: 19098066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA alloimmunization in patients requiring ventricular assist device support.
    McKenna DH; Eastlund T; Segall M; Noreen HJ; Park S
    J Heart Lung Transplant; 2002 Nov; 21(11):1218-24. PubMed ID: 12431496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosensitization does not alter post-transplant outcomes in pediatric patients bridged to transplant with a ventricular assist device.
    Castleberry C; Zafar F; Thomas T; Khan MS; Bryant R; Chin C; Morales DL; Lorts A
    Pediatr Transplant; 2016 Jun; 20(4):559-64. PubMed ID: 27102953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of anti-HLA antibodies associated with ventricular assist device use in pediatric patients: A United Network for Organ Sharing database analysis.
    Magdo HS; Schumacher KR; Yu S; Gajarski RJ; Friedland-Little JM
    Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28568969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy.
    Kirsch L; Timmermans T; Van Caenegem O; Gurne O; Noirhomme P; Jacquet LM; Latinne D; Poncelet AJ
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):268-74; discussion 274. PubMed ID: 18456505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LVAD implant as a bridge to heart transplantation is associated with allosensitization as measured by single antigen bead assay.
    Shankar N; Daly R; Geske J; Kushwaha SK; Timmons M; Joyce L; Stulak J; Gandhi M; Kremers W; Park S; Pereira NL
    Transplantation; 2013 Aug; 96(3):324-30. PubMed ID: 23743727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular assist device-associated anti-human leukocyte antigen antibody sensitization in pediatric patients bridged to heart transplantation.
    O'Connor MJ; Menteer J; Chrisant MR; Monos D; Lind C; Levine S; Gaynor JW; Hanna BD; Paridon SM; Ravishankar C; Kaufman BD
    J Heart Lung Transplant; 2010 Jan; 29(1):109-16. PubMed ID: 20123248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.